0.0001
0.0000
(0.00%)
At close: April 11 at 4:00:00 PM EDT
Key Executives
Amounts are as of December 31, 2014 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Dr. Alexander L. Weis Ph.D. | Chairman, CEO, President, CFO, Principal Accounting Officer and Secretary | 322k | -- | 1950 |
OncoVista Innovative Therapies, Inc.
14785 Omicron Drive
Suite 104
San Antonio, TX 78245
United States
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 2
Description
OncoVista Innovative Therapies, Inc., a biopharmaceutical company, develops targeted anticancer therapies by utilizing tumor-associated biomarkers. The company's product candidates include Cordycepin (OVI-123), which is in Phase I/II clinical trials for the treatment of refractory TdT positive leukemias; and L-Nucleoside Conjugates (OVI-117) that is under pre-clinical development for the treatment of colon cancer. The company was founded in 2004 and is based in San Antonio, Texas.
Corporate Governance
OncoVista Innovative Therapies, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
Upcoming Events Information Not Available
Recent Events
Recent Events Information Not Available
Related Tickers
J90.SG NurExone Biologic Inc
0.4140
+0.24%
HLUN HEALTHeUNIVERSE, Inc.
0.0000
0.00%
J90.HM NurExone Biologic Inc
0.4010
-2.43%
J90.MU NurExone Biologic Inc
0.4220
0.00%
J90.DU NurExone Biologic Inc
0.4000
-2.44%
J90.BE NurExone Biologic Inc. R
0.4240
+0.95%
W1H.F Onco-Innovations Limited
1.0600
+1.92%
NBRVF Nabriva Therapeutics plc
0.0001
0.00%
J90.F NurExone Biologic Inc.
0.4400
+7.58%
W1H.MU Onco-Innovations Ltd
1.0300
+0.98%